about
Platelet Interaction with Innate Immune CellsPlatelet activation at the onset of human endotoxemia is undetectable in vivo.Inhibition of the transcriptional repressor complex Bcl-6/BCoR induces endothelial sprouting but does not promote tumor growth.MicroRNA miR-320a modulates induction of HO-1, GCLM and OKL38 by oxidized phospholipids in endothelial cells.Myeloid but not epithelial tissue factor exerts protective anti-inflammatory effects in acid aspiration-induced acute lung injuryFibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses.Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses.Erratum: Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways.Optimized plasma preparation is essential to monitor platelet-stored molecules in humans.A novel method for automated assessment of megakaryocyte differentiation and proplatelet formation.Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation.The profile of platelet α-granule released molecules affects postoperative liver regenerationAspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytesPeriodontal treatment limits platelet activation in patients with periodontitis-a controlled-randomized intervention trialGenetic platelet depletion is superior in platelet transfusion compared to current modelsPlatelet PI3K Modulates Innate Leukocyte Extravasation during Acid-Induced Acute Lung InflammationPlatelets in Sepsis: An Update on Experimental Models and Clinical Data
P50
Q26745910-48305436-3691-41E7-A27F-13247F5F9CC2Q33429164-07D2C02B-235F-4895-9D17-F8BC849A9D7AQ37702311-B2D04A11-2309-41C1-808A-3BCB4B5349CFQ38307400-6F2A735D-2890-4B84-B4DB-41049CC85623Q38783481-627B3CE0-D920-465D-A4E3-F75461EFBD11Q38974755-C2713849-8E7B-4ADE-8722-65B520DEDB1BQ39592731-ED3D3C85-38D9-4F28-9D6E-71B228E521E7Q42235922-326F561D-2AB8-4B12-BE77-7C0D016DD949Q42767358-52FF6A22-D1CA-40B8-ACB5-980F7DEB2F2DQ42774051-77DDAD7C-F579-4B28-822A-DA2B54896FEEQ47138311-75F4EA1C-2DE9-431F-A31F-31A30BECB6F0Q52692849-52805ADB-85F6-4C4C-BB3B-C826404D27BEQ52926888-8136D3D3-3B2B-40BA-853F-5D0F9CB73953Q54395539-A56798AC-3864-4772-AC6A-6B1AC6DB3A75Q60633009-2B9E43B3-5842-4ED5-B17C-BE524E260D6BQ87170485-91D9CCDC-0654-4B7D-83A4-E102E6738AE4Q89419264-3AA91A24-A734-48EF-B72D-25B2BC03F6A3Q90182567-5697EE27-1047-4B6D-A527-AC09BDE9CAFBQ92343038-C8EC52F5-6458-4DED-8594-D962FEA70A23Q92405179-024B9646-CA1B-42BB-A271-8279EF7FF113
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0550-4120
@en
name
Waltraud C Schrottmaier
@ast
Waltraud C Schrottmaier
@en
Waltraud C Schrottmaier
@es
Waltraud C Schrottmaier
@nl
type
label
Waltraud C Schrottmaier
@ast
Waltraud C Schrottmaier
@en
Waltraud C Schrottmaier
@es
Waltraud C Schrottmaier
@nl
prefLabel
Waltraud C Schrottmaier
@ast
Waltraud C Schrottmaier
@en
Waltraud C Schrottmaier
@es
Waltraud C Schrottmaier
@nl
P106
P1153
55974694400
P31
P496
0000-0003-0550-4120